glp-1 otc drugs SAHPRA warns the public about products sold through social media platforms GLP-1 receptor agonists | How
Description
10.1016/j.cmet.2025.03.011
These finding is not unexpected since GLP-1 may increase natriuresis through the inhibition of many ion exchangers in the tubules which expression decreases with the progression of CKD and interstitial fibrosis and tubular atrophy 33
On July 1, 2025, more patients in New Zealand can access Trulicity (dulaglutide)
StatPearls Publishing (2022)
Whether the use of GLP-1RA increases the risk of thyroid cancer in humans still requires more long-term, controlled, prospective clinical studies for further confirmation
Figure 3A displays the number of reports for each specific GLP-1RA drug
